Cargando…
Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study
BACKGROUND: Ovarian cancer is one of the most lethal cancers and women with type 2 diabetes (T2D) have even poorer survival from it. We assessed the prognosis of ovarian cancer in women with type 2 diabetes treated with metformin, other forms of antidiabetic medication, or statins. METHODS: Study co...
Autores principales: | Urpilainen, Elina, Marttila, Mikko, Hautakoski, Ari, Arffman, Martti, Sund, Reijo, Ilanne-Parikka, Pirjo, Arima, Reetta, Kangaskokko, Jenni, Puistola, Ulla, Hinkula, Marianne, Läärä, Esa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064082/ https://www.ncbi.nlm.nih.gov/pubmed/30055585 http://dx.doi.org/10.1186/s12885-018-4676-z |
Ejemplares similares
-
Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes
por: Hosio, Mayu, et al.
Publicado: (2019) -
Association of antidiabetic medication and statins with survival from ductal and lobular breast carcinoma in women with type 2 diabetes
por: Hosio, Mayu, et al.
Publicado: (2021) -
The Association of Metformin, Other Antidiabetic Medications and Statins on the Prognosis of Rectal Cancer in Patients with Type 2 Diabetes: A Retrospective Cohort Study
por: Erkinantti, Sami, et al.
Publicado: (2022) -
The Association of Metformin, Other Antidiabetic Medications, and Statins With the Prognosis of Colon Cancer in Patients With Type 2 Diabetes: A Retrospective Cohort Study
por: Erkinantti, Sami, et al.
Publicado: (2022) -
No Association Between Statin Use and the Prognosis of Endometrial Cancer in Women With Type 2 Diabetes
por: Urpilainen, Elina, et al.
Publicado: (2021)